BioPharmX (BPMX): Reiterating Buy Ahead of May/June Catalyst - HC Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst, Swayampakula Ramakanth, reiterated his Buy rating on shares of BioPharmX Corp (NYSE: BPMX) ahead of BPX-01 Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
